HumanFirst operates the Atlas platform, a dataset-driven, API-enabled system that catalogs over 1,000 connected sensor technologies, more than 3,000 digital clinical measures across 150+ categories, and measures spanning 300+ medical conditions and 25 therapeutic areas. The platform helps study teams select validated wearables, build evidence for digital endpoints, run landscape analyses, and track sensor deployments across organizations. Its customers include 22 of the 25 largest pharmaceutical companies, and its tools support decentralized trials and remote patient monitoring use cases. The company emphasizes evidence, security, usability, data governance, and equitable deployment of connected products, and it follows guidance from its open-access Digital Measures Playbook. HumanFirst plans to use new funding to expand at-home sensor distribution, broaden AI and administrative capabilities, and launch new product offerings such as a historical tech catalog. The company also intends to grow headcount across product, engineering, operations, and commercialization to support operations at home. Elektra Labs builds Atlas, a catalog and assessment toolkit for biometric monitoring technologies and digital therapeutics. Atlas publishes labels—similar to drug or nutrition labels—that summarize usability, validation, utility, security and data governance for digital products. The team interviewed more than 300 professionals while developing the toolkit for pharmaceutical companies and other healthcare stakeholders and is already working with undisclosed pharma partners to map the digital therapeutic environment. Elektra aims to provide a single source for reporting adverse events, describing product provenance, assessing appropriate users, and cataloging risks and clinical evidence for connected health tools. The company emphasizes both efficacy validation and security/privacy of digital specimens, arguing for stronger data governance and informed consent baked into products. Elektra is backed by venture investors and angels and raised $2.9 million in seed funding.

Total raised

$15M

Funding rounds

2

Latest round

Series A

Latest activity

Jun 2021